We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ADVISERS VOTE NO ON P&G's FEMALE SEXUAL DESIRE DRUG
FDA ADVISERS VOTE NO ON P&G's FEMALE SEXUAL DESIRE DRUG
December 3, 2004
An FDA advisory committee has recommend the FDA not approve Procter & Gamble’s (P&G’s) experimental drug to treat low sexual desire in women who have become menopausal following surgery and are also on estrogen therapy.